EUVIMEDEUVIMED entdecken
Crossref

Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection

Christopher J Lehmann, Nicholas P Dylla, Matthew Odenwald, Ravi Nayak, Maryam Khalid, Jaye Boissiere, Jackelyn Cantoral, Emerald Adler, Matthew R Stutz, Mark Dela Cruz, Angelica Moran, Huaiying Lin und 9 weitere

Cell Host & Microbe · 2024-01 · 32 (1) · 117-130.e4

DOI: 10.1016/j.chom.2023.11.016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Host & Microbe, 2024-01. Verfasst von Christopher J Lehmann und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Section of Infectious Disease and Global Health, University of Chicago Medicine, 5841 S. Maryland Ave., Chicago, IL 60637, US…. Hauptthemen laut MEDLINE: Liver Transplantation, Gastrointestinal Microbiome. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: Bill and Melinda Gates Foundation, Seres Therapeutics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolites produced by the intestinal microbiome modulate mucosal immune defenses and optimize epithelial barrier function. Intestinal dysbiosis, including loss of intestinal microbiome diversity and expansion of antibiotic-resistant pathobionts, is accompanied by changes in fecal metabolite concentrations and increased incidence of systemic infection. Laboratory tests that quantify intestinal dysbiosis, however, have yet to be incorporated into clinical practice. We quantified fecal metabolites in 107 patients undergoing liver transplantation (LT) and correlated these with fecal microbiome compositions, pathobiont expansion, and postoperative infections. Consistent with experimental studies implicating microbiome-derived metabolites with host-mediated antimicrobial defenses, reduced fecal concentrations of short- and branched-chain fatty acids, secondary bile acids, and tryptophan metabolites correlate with compositional microbiome dysbiosis in LT patients and the relative risk of postoperative infection. Our findings demonstrate that fecal metabolite profiling can identify LT patients at increased risk of postoperative infection and may provide guideposts for microbiome-targeted therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationGastrointestinal MicrobiomeHumansDysbiosisFecesFatty Acids

Stichwörter der Autor:innen

EnterobacteralesEnterococcusinfectionliver transplantmetabolomemicrobiomemultiple-drug-resistant organismpostoperative

Substanzen

Fatty Acids

Autor:innen und Institutionen

  • Department of Medicine, Section of Infectious Disease and Global Health, University of Chicago Medicine, 5841 S. Maryland Ave., Chicago, IL 60637, USA; Department of Pediatrics, Section of Pediatric Infectious Diseases,…
  • Duchossois Family Institute, Biological Sciences Division, University of Chicago, 900 E. 57th St, Chicago, IL 60637, USA.
  • Duchossois Family Institute, Biological Sciences Division, University of Chicago, 900 E. 57th St, Chicago, IL 60637, USA; Department of Medicine, Section of Gastroenterology, Hepatology, and Nutrition, University of Chi…
  • Department of Pulmonary and Critical Care Medicine, Cook County Health, 1950 W. Polk St, Chicago, IL 60612, USA.
  • Department of Cardiology, Advocate Health Care Systems, 4400 W. 95(th) St, Oak Lawn, IL 60453, USA.
  • Department of Pathology, University of Chicago Medicine, 5841 South Maryland Ave, Chicago, IL 60637, USA.

Förderung

  • Bill and Melinda Gates Foundation
  • Seres Therapeutics

Zitieren

APA

Lehmann, C. J., Dylla, N. P., Odenwald, M., Nayak, R., Khalid, M., Boissiere, J., Cantoral, J., Adler, E., Stutz, M. R., Dela Cruz, M., Moran, A., Lin, H., Ramaswamy, R., Sundararajan, A., Sidebottom, A. M., Little, J., Pamer, E. G., Aronsohn, A., Fung, J., …, & Kacha, A. (2024). Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection. Cell Host & Microbe, 32(1), 117-130.e4. https://doi.org/10.1016/j.chom.2023.11.016

Vancouver

Lehmann CJ, Dylla NP, Odenwald M, Nayak R, Khalid M, Boissiere J, et al. Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection. Cell Host & Microbe. 2024;32(1):117-130.e4. doi:10.1016/j.chom.2023.11.016

BibTeX
@article{Lehmann2024,
  author = {Lehmann, Christopher J and Dylla, Nicholas P and Odenwald, Matthew and Nayak, Ravi and Khalid, Maryam and Boissiere, Jaye and Cantoral, Jackelyn and Adler, Emerald and Stutz, Matthew R and Dela Cruz, Mark and Moran, Angelica and Lin, Huaiying and Ramaswamy, Ramanujam and Sundararajan, Anitha and Sidebottom, Ashley M and Little, Jessica and Pamer, Eric G and Aronsohn, Andrew and Fung, John and Baker, Talia B and Kacha, Aalok},
  title = {Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection},
  journal = {Cell Host & Microbe},
  year = {2024},
  volume = {32},
  number = {1},
  pages = {117--130.e4},
  doi = {10.1016/j.chom.2023.11.016}
}
Kostenlos starten →